Top compounds associated with response to AAMDC


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC 0.12 0.03
mRNA temsirolimus FIMM pan-cancer AAC -0.0087 1
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.004 0.9
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.033 0.5
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA tandutinib CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tamatinib CTRPv2 pan-cancer AAC 0.006 0.9
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.011 0.7
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.0068 0.9
Download CSV